Addison disease - diagnosis and initial management.

BACKGROUND Adrenal insufficiency is a rare disease caused by either primary adrenal failure (Addison disease) or by impairment of the hypothalamic-pituitary-adrenal axis. Steroid replacement therapy normalises quality of life, however, adherence can be problematic. OBJECTIVE This article provides information on adrenal insufficiency focusing on awareness of initial symptoms and on risk scenarios, emergency management and baseline investigations, complete investigations and long term management. DISCUSSION Early recognition of adrenal insufficiency is essential to avoid associated morbidity and mortality. Initial diagnosis and decision to treat are based on history and physical examination. Appropriate management includes emergency resuscitation and steroid administration. Initial investigations can include sodium, potassium and blood glucose levels. However, complete investigations can be deferred. Specialist advice should be obtained and long term management includes a Team Care Arrangement. For patients, an emergency plan and emergency identification are essential.

[1]  W. Arlt The approach to the adult with newly diagnosed adrenal insufficiency. , 2009, The Journal of clinical endocrinology and metabolism.

[2]  J. Svartberg,et al.  Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. , 2008, European journal of endocrinology.

[3]  C. Deal,et al.  Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. , 2005, The Journal of clinical endocrinology and metabolism.

[4]  F. Santeusanio,et al.  Is the prevalence of Addison's disease underestimated? , 1999, The Journal of clinical endocrinology and metabolism.

[5]  S. Soule,et al.  Addison's disease in Africa—a teaching hospital experience , 1999, Clinical endocrinology.

[6]  W. Oelkers Adrenal insufficiency. , 1996, The New England journal of medicine.

[7]  J. Perheentupa,et al.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. , 1990, The New England journal of medicine.